Physicians continue to shy away from prescribing finasteride to prevent prostate cancer, despite evidence from two large clinical trials showing that the 5 alpha-reductase inhibitor (5ARI) significantly reduced the risk, a survey showed.Better not to develop prostate cancer at all and there are safer approaches than finasteride, a 5 alpha-reductase inhibitor (5ARI).
Two-thirds of urologists and 80% of primary care physicians said they had never prescribed finasteride for chemoprevention, according to survey results published online in Cancer Epidemiology, Biomarkers & Prevention.
Read up on it and then go to Anabolic Clinic to learn more.
No comments:
Post a Comment